Tag | Content |
---|
EnhancerAtlas ID | HS098-27775 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr19:36193060-36193970 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_59463 | chr19:36184851-36210443 | Ly3 | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | GGCCCCTTCC CCCATTTTAG CGGTTTCGCT CCCTATCGGG GCCAGGGACG CCTCAGGCTG 60 TCTCGGTCAG GACCTACAGC TCCGGTTGTT GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT 120 GTCTCCTGAC CACCCCCATT CCTCCCCACT CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC 180 GCGCACAACA ACACTCCGCG CAGCGGGAAG GTACCGAACT CGCATCGCAG CCTGAAACTG 240 CTCAACTAAG CTCCCGCCCC GCTGCTCTCT GGTCAATCTA AAGCGAAGAC GAGCCTTAGG 300 GCCAATCAGA AGCGACAGCG GTGGAGTCAT GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC 360 ATTGGCTATG CTTGAGAACG AATCCCAGGC TAAGCCACTT AGAAAGGAGC GGAGCCAGCC 420 AATCAGCGGT GCAACCGCCG CGGGGGCCGG GCCAGAAGCC CCGCAGACAA GCACCTCGGG 480 AGACTGGCGA GGGGCGAGCT CGCAGCTTGT TAGCCCCGAA GCCCTGCCCA GGGGGAAACC 540 CTGCTGGAGG GAGTCTAACC CCCGGGCCAG TTAATGTTGG GGCAGCGCAA TCGGCCGTTC 600 CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC TGACACGTCC GCGCGCAGTT ACTCCTGGCT 660 GAGCATACAG TCGAGGTGGC AGTGGGAATT GGAAGTGCAA GTGTCACGCT GCCAATCACG 720 GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT TCCTGTCCCT GTACACTTCC AGGCTTCCAG 780 GCGAGGCAGA GTGAGCTGTG CCAGCAATCG TGGTGGAGTG GGACAAGAGA GAAAAGGGAG 840 CTGTTCACAG GCACCGAAGC CTGGCTGGCT CTTTTTTTTT TTGAGACGCC GTCTCGCTCT 900 GTCTCCCAGG 910
|